Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography | 182 | 2024 | 4962 | 4.810 |
Why?
|
Cardiomyopathy, Hypertrophic | 45 | 2023 | 1309 | 3.650 |
Why?
|
Cardiomyopathy, Dilated | 42 | 2024 | 818 | 3.380 |
Why?
|
Heart Ventricles | 95 | 2023 | 3806 | 3.370 |
Why?
|
Heart Defects, Congenital | 97 | 2024 | 4673 | 3.050 |
Why?
|
Ventricular Function, Left | 85 | 2024 | 3858 | 2.960 |
Why?
|
Myocardial Contraction | 62 | 2020 | 1516 | 2.830 |
Why?
|
Ventricular Dysfunction, Left | 45 | 2020 | 2115 | 2.480 |
Why?
|
Aortic Valve Insufficiency | 23 | 2023 | 578 | 2.420 |
Why?
|
Echocardiography, Doppler | 38 | 2024 | 898 | 2.360 |
Why?
|
Heart | 45 | 2023 | 4382 | 1.830 |
Why?
|
Cardiomyopathies | 27 | 2024 | 1944 | 1.730 |
Why?
|
Sarcomeres | 15 | 2020 | 367 | 1.640 |
Why?
|
Heart Transplantation | 36 | 2022 | 3220 | 1.470 |
Why?
|
Transposition of Great Vessels | 27 | 2023 | 590 | 1.420 |
Why?
|
Aortic Valve Stenosis | 31 | 2020 | 2002 | 1.360 |
Why?
|
Infant | 216 | 2023 | 36055 | 1.340 |
Why?
|
Hypertrophy, Left Ventricular | 24 | 2023 | 849 | 1.330 |
Why?
|
Child, Preschool | 221 | 2023 | 42062 | 1.330 |
Why?
|
Ventricular Remodeling | 22 | 2024 | 1256 | 1.290 |
Why?
|
Child | 273 | 2024 | 79818 | 1.280 |
Why?
|
Cardiac Surgical Procedures | 34 | 2023 | 3603 | 1.250 |
Why?
|
Antibiotics, Antineoplastic | 11 | 2023 | 675 | 1.200 |
Why?
|
Doxorubicin | 16 | 2023 | 2209 | 1.200 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 15 | 2015 | 537 | 1.080 |
Why?
|
Diastole | 28 | 2022 | 781 | 1.060 |
Why?
|
Fontan Procedure | 20 | 2018 | 791 | 1.040 |
Why?
|
Heart Septal Defects, Ventricular | 21 | 2023 | 491 | 0.960 |
Why?
|
Infant, Newborn | 140 | 2023 | 26183 | 0.950 |
Why?
|
Adolescent | 198 | 2023 | 87892 | 0.910 |
Why?
|
Body Surface Area | 8 | 2021 | 197 | 0.910 |
Why?
|
Registries | 40 | 2024 | 8175 | 0.850 |
Why?
|
Heart Valve Diseases | 10 | 2023 | 1033 | 0.840 |
Why?
|
Heart Atria | 15 | 2023 | 1344 | 0.820 |
Why?
|
Aortic Diseases | 9 | 2023 | 735 | 0.820 |
Why?
|
Hypoplastic Left Heart Syndrome | 13 | 2014 | 594 | 0.800 |
Why?
|
Heart Diseases | 20 | 2024 | 2782 | 0.790 |
Why?
|
Stroke Volume | 49 | 2024 | 5460 | 0.780 |
Why?
|
Mitral Valve Insufficiency | 12 | 2023 | 1401 | 0.750 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 | 2023 | 1547 | 0.740 |
Why?
|
Heart Failure | 30 | 2024 | 11593 | 0.720 |
Why?
|
Magnetic Resonance Imaging, Cine | 15 | 2023 | 1044 | 0.690 |
Why?
|
Heart Bypass, Right | 7 | 2017 | 75 | 0.690 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 3 | 2018 | 22 | 0.680 |
Why?
|
Cardiac Volume | 9 | 2018 | 199 | 0.670 |
Why?
|
Aortic Coarctation | 11 | 2013 | 282 | 0.670 |
Why?
|
Death, Sudden, Cardiac | 11 | 2022 | 1554 | 0.660 |
Why?
|
Humans | 469 | 2024 | 758406 | 0.660 |
Why?
|
Ventricular Function | 17 | 2017 | 406 | 0.660 |
Why?
|
Ventricular Outflow Obstruction | 10 | 2020 | 261 | 0.660 |
Why?
|
Pulmonary Artery | 19 | 2013 | 1915 | 0.640 |
Why?
|
Postoperative Complications | 40 | 2021 | 15637 | 0.640 |
Why?
|
Hemodynamics | 35 | 2015 | 4159 | 0.630 |
Why?
|
Heart Septal Defects, Atrial | 9 | 2022 | 460 | 0.630 |
Why?
|
Male | 281 | 2024 | 358747 | 0.620 |
Why?
|
Anti-Retroviral Agents | 4 | 2020 | 1780 | 0.620 |
Why?
|
American Heart Association | 4 | 2023 | 1039 | 0.620 |
Why?
|
Echocardiography, Three-Dimensional | 7 | 2018 | 606 | 0.610 |
Why?
|
Adrenergic beta-Antagonists | 11 | 2018 | 1240 | 0.610 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 463 | 0.600 |
Why?
|
Female | 293 | 2024 | 390323 | 0.590 |
Why?
|
Myocardium | 24 | 2023 | 4690 | 0.590 |
Why?
|
Pulmonary Valve Stenosis | 6 | 2023 | 172 | 0.580 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 6 | 2020 | 431 | 0.580 |
Why?
|
Dilatation, Pathologic | 18 | 2023 | 527 | 0.580 |
Why?
|
Terminology as Topic | 12 | 2018 | 1533 | 0.580 |
Why?
|
Arrhythmias, Cardiac | 15 | 2020 | 2248 | 0.560 |
Why?
|
Tricuspid Valve Insufficiency | 4 | 2020 | 353 | 0.560 |
Why?
|
Pulmonary Atresia | 5 | 2023 | 159 | 0.560 |
Why?
|
Systole | 25 | 2019 | 936 | 0.550 |
Why?
|
Atenolol | 5 | 2020 | 99 | 0.550 |
Why?
|
Cardiomyopathy, Restrictive | 4 | 2023 | 61 | 0.540 |
Why?
|
Pregnancy Complications, Infectious | 7 | 2020 | 2125 | 0.540 |
Why?
|
Razoxane | 3 | 2012 | 43 | 0.530 |
Why?
|
Norwood Procedures | 6 | 2016 | 192 | 0.520 |
Why?
|
Pediatrics | 20 | 2021 | 3587 | 0.510 |
Why?
|
Cardiac Myosins | 5 | 2020 | 127 | 0.510 |
Why?
|
Anthracyclines | 7 | 2024 | 282 | 0.510 |
Why?
|
Catheterization | 9 | 2010 | 1426 | 0.500 |
Why?
|
Iron Overload | 4 | 2023 | 240 | 0.490 |
Why?
|
Follow-Up Studies | 81 | 2023 | 39059 | 0.490 |
Why?
|
Retrospective Studies | 107 | 2023 | 80168 | 0.490 |
Why?
|
Body Height | 5 | 2021 | 1567 | 0.490 |
Why?
|
Cardiomegaly | 12 | 2021 | 591 | 0.490 |
Why?
|
HIV Infections | 28 | 2020 | 17275 | 0.490 |
Why?
|
Losartan | 5 | 2020 | 265 | 0.490 |
Why?
|
Body Size | 3 | 2022 | 462 | 0.480 |
Why?
|
Cardiology | 9 | 2024 | 1667 | 0.480 |
Why?
|
Aortic Valve | 13 | 2018 | 1950 | 0.470 |
Why?
|
Myosin Heavy Chains | 5 | 2020 | 402 | 0.470 |
Why?
|
Enalapril | 4 | 2019 | 311 | 0.470 |
Why?
|
Young Adult | 72 | 2024 | 58808 | 0.460 |
Why?
|
Mitral Valve | 10 | 2023 | 1466 | 0.440 |
Why?
|
Prospective Studies | 76 | 2023 | 54137 | 0.440 |
Why?
|
Aorta, Thoracic | 9 | 2023 | 1094 | 0.430 |
Why?
|
Atrial Function, Left | 3 | 2017 | 184 | 0.430 |
Why?
|
Treatment Outcome | 88 | 2024 | 64378 | 0.430 |
Why?
|
International Classification of Diseases | 5 | 2021 | 892 | 0.430 |
Why?
|
Models, Cardiovascular | 6 | 2015 | 972 | 0.420 |
Why?
|
Coronary Vessels | 14 | 2013 | 3072 | 0.420 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2018 | 1895 | 0.410 |
Why?
|
Risk Factors | 76 | 2023 | 73809 | 0.400 |
Why?
|
Graft Rejection | 4 | 2020 | 4426 | 0.400 |
Why?
|
Reproducibility of Results | 36 | 2023 | 20055 | 0.400 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2018 | 3339 | 0.400 |
Why?
|
Ventricular Pressure | 7 | 2019 | 204 | 0.400 |
Why?
|
Carotid Arteries | 3 | 2014 | 939 | 0.400 |
Why?
|
HIV Seropositivity | 3 | 2013 | 960 | 0.390 |
Why?
|
Marfan Syndrome | 4 | 2018 | 236 | 0.390 |
Why?
|
Reference Values | 16 | 2023 | 4919 | 0.380 |
Why?
|
Survivors | 9 | 2023 | 2370 | 0.380 |
Why?
|
Biometry | 2 | 2013 | 559 | 0.380 |
Why?
|
Societies, Medical | 11 | 2021 | 3891 | 0.370 |
Why?
|
Cardiotoxins | 3 | 2017 | 36 | 0.370 |
Why?
|
Aorta | 14 | 2018 | 2037 | 0.360 |
Why?
|
Ventricular Function, Right | 6 | 2018 | 609 | 0.360 |
Why?
|
Time Factors | 60 | 2019 | 39872 | 0.350 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 7 | 2011 | 1503 | 0.340 |
Why?
|
Adult | 121 | 2024 | 219935 | 0.340 |
Why?
|
Cardiotonic Agents | 6 | 2016 | 539 | 0.340 |
Why?
|
Zidovudine | 3 | 2012 | 624 | 0.340 |
Why?
|
Heart Septum | 9 | 2020 | 303 | 0.340 |
Why?
|
Heart Septal Defects | 5 | 2017 | 191 | 0.330 |
Why?
|
Amlodipine | 3 | 2023 | 84 | 0.330 |
Why?
|
Coronary Vessel Anomalies | 9 | 1999 | 308 | 0.320 |
Why?
|
Hypertrophy, Right Ventricular | 3 | 2000 | 105 | 0.320 |
Why?
|
Risk Assessment | 34 | 2023 | 23884 | 0.320 |
Why?
|
beta-Thalassemia | 2 | 2023 | 235 | 0.320 |
Why?
|
Noonan Syndrome | 3 | 2023 | 120 | 0.320 |
Why?
|
Immunoglobulins, Intravenous | 5 | 2010 | 664 | 0.320 |
Why?
|
Death, Sudden | 1 | 2010 | 302 | 0.310 |
Why?
|
Cardiovascular System | 3 | 2004 | 835 | 0.310 |
Why?
|
Ultrasonography | 21 | 2013 | 5952 | 0.310 |
Why?
|
Cardiovascular Agents | 3 | 2010 | 839 | 0.310 |
Why?
|
Age Factors | 33 | 2020 | 18358 | 0.300 |
Why?
|
Canada | 10 | 2019 | 2111 | 0.300 |
Why?
|
Tetralogy of Fallot | 4 | 2023 | 631 | 0.300 |
Why?
|
Genetic Testing | 5 | 2022 | 3530 | 0.290 |
Why?
|
Natriuretic Peptide, Brain | 9 | 2018 | 1704 | 0.290 |
Why?
|
Incidence | 33 | 2022 | 21272 | 0.290 |
Why?
|
Organ Size | 9 | 2022 | 2252 | 0.290 |
Why?
|
Survival Rate | 26 | 2021 | 12721 | 0.290 |
Why?
|
Predictive Value of Tests | 28 | 2023 | 15225 | 0.280 |
Why?
|
Echocardiography, Stress | 3 | 2020 | 134 | 0.280 |
Why?
|
Health Status | 11 | 2018 | 4071 | 0.280 |
Why?
|
Infectious Disease Transmission, Vertical | 11 | 2015 | 1348 | 0.270 |
Why?
|
Muscular Dystrophy, Duchenne | 2 | 2008 | 268 | 0.270 |
Why?
|
Propanolamines | 3 | 2016 | 162 | 0.270 |
Why?
|
Boston | 17 | 2023 | 9304 | 0.270 |
Why?
|
Practice Guidelines as Topic | 8 | 2022 | 7378 | 0.270 |
Why?
|
Calcium Channel Blockers | 5 | 2023 | 694 | 0.260 |
Why?
|
Blood Pressure | 19 | 2019 | 8451 | 0.260 |
Why?
|
Lung Transplantation | 1 | 2015 | 1305 | 0.260 |
Why?
|
Electrocardiography | 28 | 2018 | 6363 | 0.260 |
Why?
|
Waiting Lists | 2 | 2012 | 762 | 0.260 |
Why?
|
Fetal Heart | 6 | 2006 | 281 | 0.250 |
Why?
|
Exercise Test | 15 | 2022 | 2121 | 0.250 |
Why?
|
Troponin T | 6 | 2018 | 761 | 0.250 |
Why?
|
Aortic Aneurysm | 3 | 2015 | 648 | 0.250 |
Why?
|
Ventricular Dysfunction | 4 | 2016 | 144 | 0.250 |
Why?
|
Algorithms | 7 | 2020 | 13961 | 0.250 |
Why?
|
Carbazoles | 3 | 2016 | 220 | 0.250 |
Why?
|
Genotype | 13 | 2022 | 12945 | 0.250 |
Why?
|
Prognosis | 37 | 2023 | 29557 | 0.240 |
Why?
|
United States | 44 | 2024 | 72136 | 0.240 |
Why?
|
Disease Progression | 25 | 2022 | 13468 | 0.240 |
Why?
|
Vascular Surgical Procedures | 4 | 2012 | 1470 | 0.240 |
Why?
|
Cardiopulmonary Bypass | 2 | 2002 | 1093 | 0.240 |
Why?
|
Phenotype | 20 | 2023 | 16534 | 0.240 |
Why?
|
Reoperation | 15 | 2023 | 4282 | 0.240 |
Why?
|
Severity of Illness Index | 19 | 2020 | 15785 | 0.240 |
Why?
|
Pulmonary Valve | 11 | 2016 | 412 | 0.240 |
Why?
|
Tachycardia, Supraventricular | 6 | 2007 | 273 | 0.230 |
Why?
|
Mutation | 15 | 2021 | 29915 | 0.230 |
Why?
|
Multivariate Analysis | 22 | 2017 | 12096 | 0.230 |
Why?
|
Kaplan-Meier Estimate | 13 | 2018 | 6493 | 0.230 |
Why?
|
Aftercare | 4 | 2022 | 910 | 0.230 |
Why?
|
Maternal Exposure | 2 | 2011 | 1045 | 0.230 |
Why?
|
Databases, Factual | 10 | 2021 | 7980 | 0.230 |
Why?
|
Sensitivity and Specificity | 22 | 2016 | 14641 | 0.230 |
Why?
|
Blood Flow Velocity | 9 | 2016 | 1370 | 0.230 |
Why?
|
HIV | 2 | 2011 | 1581 | 0.230 |
Why?
|
Survival Analysis | 15 | 2015 | 10112 | 0.230 |
Why?
|
ROC Curve | 10 | 2020 | 3563 | 0.220 |
Why?
|
Mutation, Missense | 4 | 2021 | 2564 | 0.220 |
Why?
|
LEOPARD Syndrome | 1 | 2023 | 12 | 0.220 |
Why?
|
Triiodothyronine | 4 | 2016 | 493 | 0.220 |
Why?
|
Heart Valves | 3 | 2020 | 284 | 0.220 |
Why?
|
Vena Cava, Superior | 2 | 2006 | 197 | 0.220 |
Why?
|
Human Growth Hormone | 2 | 2005 | 638 | 0.220 |
Why?
|
Patient Care Management | 3 | 2011 | 302 | 0.220 |
Why?
|
Cardiography, Impedance | 1 | 2003 | 40 | 0.220 |
Why?
|
Proportional Hazards Models | 17 | 2020 | 12440 | 0.210 |
Why?
|
Foramen Ovale | 1 | 2022 | 17 | 0.210 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2015 | 2496 | 0.210 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 2 | 2020 | 30 | 0.210 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2023 | 63 | 0.210 |
Why?
|
Endocardium | 3 | 2000 | 246 | 0.210 |
Why?
|
Cohort Studies | 34 | 2022 | 41256 | 0.210 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2003 | 100 | 0.210 |
Why?
|
Single-Blind Method | 4 | 2017 | 1570 | 0.210 |
Why?
|
Atrial Septum | 1 | 2022 | 60 | 0.210 |
Why?
|
Anthropometry | 3 | 2004 | 1347 | 0.200 |
Why?
|
Thalassemia | 3 | 2014 | 270 | 0.200 |
Why?
|
Mortality | 3 | 2020 | 2886 | 0.200 |
Why?
|
Image Enhancement | 4 | 2016 | 2880 | 0.200 |
Why?
|
Ultrasonography, Prenatal | 9 | 2013 | 1745 | 0.200 |
Why?
|
Consensus | 3 | 2018 | 3099 | 0.200 |
Why?
|
Cross-Sectional Studies | 28 | 2018 | 25956 | 0.200 |
Why?
|
Progeria | 1 | 2024 | 188 | 0.200 |
Why?
|
Observer Variation | 6 | 2017 | 2600 | 0.200 |
Why?
|
Atrial Fibrillation | 6 | 2021 | 5103 | 0.200 |
Why?
|
Myocytes, Cardiac | 3 | 2020 | 1655 | 0.190 |
Why?
|
Double Outlet Right Ventricle | 4 | 2010 | 60 | 0.190 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2021 | 43 | 0.190 |
Why?
|
Heart Function Tests | 4 | 2012 | 318 | 0.190 |
Why?
|
Length of Stay | 14 | 2019 | 6439 | 0.190 |
Why?
|
Tricuspid Valve | 10 | 2018 | 408 | 0.190 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2012 | 695 | 0.190 |
Why?
|
Morbidity | 7 | 2021 | 1754 | 0.190 |
Why?
|
Quality Improvement | 7 | 2018 | 3806 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 14 | 2023 | 17768 | 0.180 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15399 | 0.180 |
Why?
|
Pregnancy | 24 | 2020 | 29742 | 0.180 |
Why?
|
Cardiology Service, Hospital | 3 | 2011 | 239 | 0.180 |
Why?
|
Quality Indicators, Health Care | 4 | 2015 | 1797 | 0.180 |
Why?
|
Defibrillators, Implantable | 5 | 2020 | 1487 | 0.170 |
Why?
|
Clinical Competence | 6 | 2016 | 4775 | 0.170 |
Why?
|
Fibrosis | 9 | 2023 | 2038 | 0.170 |
Why?
|
Exercise | 7 | 2012 | 5788 | 0.170 |
Why?
|
Inheritance Patterns | 1 | 2022 | 340 | 0.170 |
Why?
|
Myocarditis | 7 | 2012 | 766 | 0.170 |
Why?
|
Preoperative Care | 7 | 2003 | 2249 | 0.160 |
Why?
|
Longitudinal Studies | 17 | 2018 | 14490 | 0.160 |
Why?
|
Scoliosis | 3 | 2003 | 734 | 0.160 |
Why?
|
Coronary Circulation | 6 | 2016 | 1561 | 0.160 |
Why?
|
Pulmonary Veins | 4 | 2011 | 745 | 0.160 |
Why?
|
Iron | 4 | 2023 | 1786 | 0.160 |
Why?
|
Osteosarcoma | 2 | 2023 | 897 | 0.160 |
Why?
|
Pulse | 4 | 2009 | 218 | 0.160 |
Why?
|
Patient Discharge | 5 | 2022 | 3433 | 0.160 |
Why?
|
Aging | 7 | 2024 | 8650 | 0.160 |
Why?
|
Life Tables | 5 | 2006 | 365 | 0.160 |
Why?
|
Linear Models | 12 | 2018 | 5862 | 0.160 |
Why?
|
Dobutamine | 4 | 1992 | 116 | 0.160 |
Why?
|
Oxygen Consumption | 3 | 2016 | 1845 | 0.160 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2004 | 615 | 0.160 |
Why?
|
Mitral Valve Stenosis | 4 | 2023 | 345 | 0.160 |
Why?
|
Electric Countershock | 2 | 2020 | 533 | 0.150 |
Why?
|
Hospitals, Pediatric | 6 | 2016 | 1854 | 0.150 |
Why?
|
Postoperative Period | 10 | 2018 | 1812 | 0.150 |
Why?
|
Atrial Function | 1 | 2018 | 99 | 0.150 |
Why?
|
Chelation Therapy | 1 | 2018 | 77 | 0.150 |
Why?
|
Echocardiography, Doppler, Color | 7 | 2016 | 352 | 0.150 |
Why?
|
Genetic Variation | 4 | 2022 | 6548 | 0.150 |
Why?
|
Forms and Records Control | 2 | 2017 | 158 | 0.150 |
Why?
|
Vasodilator Agents | 2 | 1998 | 973 | 0.150 |
Why?
|
Disease-Free Survival | 8 | 2017 | 6821 | 0.150 |
Why?
|
Fetal Diseases | 5 | 2010 | 911 | 0.150 |
Why?
|
Cardiovascular Abnormalities | 3 | 2011 | 143 | 0.150 |
Why?
|
Verapamil | 1 | 1998 | 242 | 0.150 |
Why?
|
Contrast Media | 2 | 2023 | 5298 | 0.150 |
Why?
|
Echocardiography, Doppler, Pulsed | 3 | 2014 | 69 | 0.150 |
Why?
|
Double-Blind Method | 11 | 2024 | 12262 | 0.140 |
Why?
|
Sheep | 11 | 2000 | 1441 | 0.140 |
Why?
|
Methoxamine | 4 | 1985 | 45 | 0.140 |
Why?
|
Catecholamines | 3 | 2016 | 385 | 0.140 |
Why?
|
Heart-Assist Devices | 4 | 2021 | 1279 | 0.140 |
Why?
|
Critical Pathways | 2 | 2010 | 473 | 0.140 |
Why?
|
Recovery of Function | 4 | 2019 | 2970 | 0.140 |
Why?
|
Sports | 2 | 1997 | 699 | 0.130 |
Why?
|
Child Nutrition Disorders | 1 | 2018 | 150 | 0.130 |
Why?
|
Drug Administration Schedule | 7 | 2018 | 4839 | 0.130 |
Why?
|
Analysis of Variance | 10 | 2018 | 6234 | 0.130 |
Why?
|
North America | 6 | 2017 | 1276 | 0.130 |
Why?
|
Pacemaker, Artificial | 3 | 2012 | 808 | 0.130 |
Why?
|
Electrocardiography, Ambulatory | 10 | 2007 | 576 | 0.130 |
Why?
|
Quality-Adjusted Life Years | 2 | 2012 | 1722 | 0.130 |
Why?
|
Adaptation, Physiological | 5 | 2015 | 1295 | 0.130 |
Why?
|
Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
Blood Transfusion | 2 | 2018 | 1321 | 0.130 |
Why?
|
Cardiac Output | 6 | 2016 | 837 | 0.130 |
Why?
|
Carrier Proteins | 5 | 2021 | 4938 | 0.130 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2016 | 0.130 |
Why?
|
Peptide Fragments | 4 | 2013 | 5098 | 0.130 |
Why?
|
Iron Chelating Agents | 2 | 2023 | 138 | 0.130 |
Why?
|
Perinatal Care | 1 | 2017 | 242 | 0.120 |
Why?
|
Catheter Ablation | 8 | 2007 | 2740 | 0.120 |
Why?
|
Heart Rate | 11 | 2021 | 4166 | 0.120 |
Why?
|
Receptors, Adrenergic | 1 | 2014 | 155 | 0.120 |
Why?
|
Infusions, Intravenous | 7 | 2012 | 2210 | 0.120 |
Why?
|
Pulmonary Circulation | 2 | 2015 | 743 | 0.120 |
Why?
|
Diltiazem | 1 | 2014 | 131 | 0.120 |
Why?
|
Time | 1 | 2016 | 543 | 0.120 |
Why?
|
Swimming | 3 | 1991 | 206 | 0.120 |
Why?
|
Fetal Therapies | 2 | 2006 | 101 | 0.120 |
Why?
|
Neoplasms | 8 | 2024 | 22032 | 0.120 |
Why?
|
Hypertension | 7 | 2002 | 8499 | 0.120 |
Why?
|
Odds Ratio | 9 | 2015 | 9650 | 0.110 |
Why?
|
Quality of Life | 6 | 2017 | 13285 | 0.110 |
Why?
|
Case-Control Studies | 11 | 2022 | 22029 | 0.110 |
Why?
|
Chi-Square Distribution | 7 | 2014 | 3425 | 0.110 |
Why?
|
Stress, Mechanical | 7 | 2009 | 1664 | 0.110 |
Why?
|
Creatine Kinase | 5 | 2006 | 686 | 0.110 |
Why?
|
Anti-HIV Agents | 3 | 2012 | 4504 | 0.110 |
Why?
|
Tricuspid Atresia | 1 | 2013 | 37 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11709 | 0.110 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 943 | 0.110 |
Why?
|
Cause of Death | 6 | 2018 | 3675 | 0.110 |
Why?
|
Prevalence | 13 | 2018 | 15651 | 0.110 |
Why?
|
Calcium Channels, L-Type | 1 | 2014 | 240 | 0.110 |
Why?
|
Zalcitabine | 1 | 2012 | 43 | 0.110 |
Why?
|
Dilatation | 3 | 2023 | 307 | 0.110 |
Why?
|
Age of Onset | 4 | 2022 | 3298 | 0.110 |
Why?
|
Heterozygote | 3 | 2014 | 2797 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2011 | 932 | 0.110 |
Why?
|
Kidney Failure, Chronic | 3 | 2015 | 2457 | 0.110 |
Why?
|
Coronary Aneurysm | 1 | 2015 | 231 | 0.110 |
Why?
|
Logistic Models | 14 | 2015 | 13276 | 0.100 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 190 | 0.100 |
Why?
|
Middle Aged | 41 | 2021 | 219568 | 0.100 |
Why?
|
Dideoxynucleosides | 1 | 2013 | 131 | 0.100 |
Why?
|
Australia | 4 | 2018 | 1276 | 0.100 |
Why?
|
Immunoglobulins | 1 | 1995 | 859 | 0.100 |
Why?
|
Patient Selection | 6 | 2012 | 4244 | 0.100 |
Why?
|
Models, Statistical | 3 | 2020 | 5070 | 0.100 |
Why?
|
Exercise Tolerance | 3 | 2015 | 830 | 0.100 |
Why?
|
Decision Support Techniques | 3 | 2023 | 1996 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 15 | 2018 | 36284 | 0.100 |
Why?
|
History, 21st Century | 3 | 2017 | 1573 | 0.100 |
Why?
|
Hemochromatosis | 1 | 2013 | 174 | 0.100 |
Why?
|
Palliative Care | 9 | 2013 | 3570 | 0.100 |
Why?
|
Subclavian Artery | 1 | 1992 | 134 | 0.100 |
Why?
|
Immunization, Passive | 3 | 1994 | 616 | 0.100 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2012 | 138 | 0.100 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2011 | 64 | 0.100 |
Why?
|
Biopsy | 3 | 2020 | 6768 | 0.100 |
Why?
|
Ventricular Fibrillation | 2 | 2012 | 537 | 0.090 |
Why?
|
Costello Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
Hospital Costs | 3 | 2014 | 960 | 0.090 |
Why?
|
Connecticut | 1 | 2011 | 365 | 0.090 |
Why?
|
Myocardial Bridging | 1 | 2010 | 10 | 0.090 |
Why?
|
Forecasting | 3 | 2017 | 2923 | 0.090 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 69 | 0.090 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13591 | 0.090 |
Why?
|
Databases as Topic | 2 | 2012 | 472 | 0.090 |
Why?
|
Comorbidity | 5 | 2012 | 10495 | 0.090 |
Why?
|
Thyroid Hormone Resistance Syndrome | 2 | 2001 | 15 | 0.090 |
Why?
|
Hospital Mortality | 8 | 2013 | 5272 | 0.090 |
Why?
|
Postoperative Care | 2 | 2016 | 1471 | 0.090 |
Why?
|
Troponin | 3 | 2010 | 500 | 0.090 |
Why?
|
Corrosion Casting | 2 | 2000 | 15 | 0.090 |
Why?
|
Coronary Artery Disease | 4 | 2012 | 6362 | 0.090 |
Why?
|
Ontario | 3 | 2017 | 397 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2531 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2015 | 8945 | 0.090 |
Why?
|
Heart Arrest | 2 | 2020 | 1494 | 0.090 |
Why?
|
Silicone Elastomers | 2 | 2000 | 78 | 0.090 |
Why?
|
Dextrocardia | 1 | 2010 | 37 | 0.090 |
Why?
|
Transplantation | 1 | 2012 | 218 | 0.090 |
Why?
|
Vinblastine | 1 | 2011 | 487 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5649 | 0.090 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2011 | 168 | 0.090 |
Why?
|
History, 20th Century | 3 | 2017 | 2772 | 0.090 |
Why?
|
Procollagen | 1 | 2010 | 187 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2017 | 4761 | 0.090 |
Why?
|
Wounds and Injuries | 2 | 2012 | 2476 | 0.090 |
Why?
|
Radiography | 7 | 2013 | 6954 | 0.080 |
Why?
|
Postpartum Period | 1 | 1996 | 1167 | 0.080 |
Why?
|
Anastomosis, Surgical | 5 | 2012 | 983 | 0.080 |
Why?
|
Child of Impaired Parents | 1 | 2013 | 459 | 0.080 |
Why?
|
Muscular Dystrophies | 2 | 2007 | 389 | 0.080 |
Why?
|
Puerto Rico | 1 | 2010 | 373 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2010 | 1486 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1501 | 0.080 |
Why?
|
Databases, Genetic | 1 | 2016 | 1737 | 0.080 |
Why?
|
Pilot Projects | 8 | 2020 | 8553 | 0.080 |
Why?
|
Ferritins | 3 | 2023 | 597 | 0.080 |
Why?
|
Cost of Illness | 1 | 2018 | 1936 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2016 | 1327 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2016 | 1547 | 0.080 |
Why?
|
Models, Biological | 1 | 2004 | 9460 | 0.080 |
Why?
|
Tachycardia, Ventricular | 3 | 2012 | 1297 | 0.080 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2010 | 776 | 0.080 |
Why?
|
Fever | 3 | 2013 | 1617 | 0.080 |
Why?
|
Friedreich Ataxia | 1 | 2008 | 77 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2000 | 3561 | 0.070 |
Why?
|
Tachycardia | 4 | 2004 | 600 | 0.070 |
Why?
|
Standard of Care | 1 | 2011 | 550 | 0.070 |
Why?
|
Ablation Techniques | 1 | 2010 | 248 | 0.070 |
Why?
|
Syncope | 1 | 2010 | 427 | 0.070 |
Why?
|
Animals, Newborn | 3 | 2003 | 2672 | 0.070 |
Why?
|
Aorta, Abdominal | 1 | 2010 | 625 | 0.070 |
Why?
|
Abnormalities, Multiple | 4 | 2004 | 1414 | 0.070 |
Why?
|
Diagnosis, Differential | 8 | 2007 | 12951 | 0.070 |
Why?
|
Turner Syndrome | 1 | 2008 | 130 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1739 | 0.070 |
Why?
|
Sex Factors | 7 | 2017 | 10504 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 733 | 0.070 |
Why?
|
Aged | 23 | 2023 | 168218 | 0.070 |
Why?
|
American Hospital Association | 1 | 2005 | 27 | 0.070 |
Why?
|
Models, Molecular | 1 | 2016 | 5410 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 1245 | 0.070 |
Why?
|
Discriminant Analysis | 1 | 2006 | 222 | 0.070 |
Why?
|
World Health Organization | 3 | 2021 | 1312 | 0.060 |
Why?
|
Child Development | 2 | 2014 | 2285 | 0.060 |
Why?
|
Age Distribution | 3 | 2014 | 2882 | 0.060 |
Why?
|
ras Proteins | 1 | 2011 | 1049 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2007 | 384 | 0.060 |
Why?
|
Consanguinity | 2 | 2006 | 456 | 0.060 |
Why?
|
Cardiac Imaging Techniques | 2 | 2018 | 267 | 0.060 |
Why?
|
Gestational Age | 8 | 2010 | 3565 | 0.060 |
Why?
|
Data Collection | 3 | 2023 | 3322 | 0.060 |
Why?
|
Daunorubicin | 1 | 1985 | 156 | 0.060 |
Why?
|
Advisory Committees | 3 | 2017 | 785 | 0.060 |
Why?
|
Renal Dialysis | 3 | 2015 | 1786 | 0.060 |
Why?
|
Body Surface Potential Mapping | 2 | 1997 | 228 | 0.060 |
Why?
|
Methotrexate | 1 | 2011 | 1719 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1593 | 0.060 |
Why?
|
Endocardial Fibroelastosis | 1 | 2005 | 56 | 0.060 |
Why?
|
Isoenzymes | 3 | 2003 | 1686 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2500 | 0.060 |
Why?
|
Ebstein Anomaly | 1 | 2005 | 101 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1003 | 0.060 |
Why?
|
Career Choice | 1 | 2011 | 752 | 0.060 |
Why?
|
Heart Block | 3 | 2004 | 392 | 0.060 |
Why?
|
Sports Medicine | 1 | 1987 | 243 | 0.060 |
Why?
|
Axillary Artery | 1 | 1984 | 47 | 0.060 |
Why?
|
Ethanol | 1 | 2010 | 1323 | 0.060 |
Why?
|
Pregnancy Trimester, Second | 3 | 1996 | 732 | 0.060 |
Why?
|
Coronary Disease | 4 | 2007 | 5917 | 0.060 |
Why?
|
Myopathy, Central Core | 1 | 2003 | 4 | 0.060 |
Why?
|
Sex Distribution | 2 | 2014 | 2284 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3364 | 0.060 |
Why?
|
Immunologic Factors | 2 | 2010 | 1585 | 0.060 |
Why?
|
Health Resources | 1 | 2010 | 931 | 0.060 |
Why?
|
Weight Lifting | 3 | 1992 | 126 | 0.060 |
Why?
|
United Arab Emirates | 1 | 2003 | 48 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1477 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11892 | 0.060 |
Why?
|
Oklahoma | 1 | 2003 | 36 | 0.060 |
Why?
|
Vascular Resistance | 3 | 2016 | 930 | 0.060 |
Why?
|
Southwestern United States | 1 | 2003 | 39 | 0.060 |
Why?
|
Myosins | 2 | 2010 | 405 | 0.060 |
Why?
|
Troponin I | 2 | 2014 | 632 | 0.050 |
Why?
|
Truncus Arteriosus | 1 | 2023 | 22 | 0.050 |
Why?
|
Intensive Care Units | 4 | 2013 | 3732 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2018 | 4412 | 0.050 |
Why?
|
Polymorphism, Genetic | 3 | 2020 | 4284 | 0.050 |
Why?
|
Drug Therapy, Combination | 4 | 2018 | 6293 | 0.050 |
Why?
|
Infant Welfare | 1 | 2003 | 80 | 0.050 |
Why?
|
Torticollis | 1 | 2003 | 64 | 0.050 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2016 | 1014 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 821 | 0.050 |
Why?
|
Mediastinum | 1 | 2004 | 266 | 0.050 |
Why?
|
Rabbits | 3 | 2009 | 4772 | 0.050 |
Why?
|
Hypopituitarism | 1 | 2005 | 250 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 4 | 1994 | 2197 | 0.050 |
Why?
|
Endocarditis, Bacterial | 1 | 2007 | 442 | 0.050 |
Why?
|
Mathematical Computing | 1 | 2003 | 142 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 2011 | 1054 | 0.050 |
Why?
|
Physical Exertion | 1 | 1985 | 662 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 321 | 0.050 |
Why?
|
Down Syndrome | 1 | 2010 | 892 | 0.050 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2006 | 378 | 0.050 |
Why?
|
Blalock-Taussig Procedure | 2 | 2013 | 60 | 0.050 |
Why?
|
Animals | 22 | 2020 | 167768 | 0.050 |
Why?
|
Receptors, Thyroid Hormone | 2 | 2001 | 199 | 0.050 |
Why?
|
Uremia | 1 | 2003 | 201 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2167 | 0.050 |
Why?
|
Fourier Analysis | 1 | 2003 | 439 | 0.050 |
Why?
|
Regression Analysis | 4 | 2007 | 6354 | 0.050 |
Why?
|
Captopril | 1 | 1982 | 265 | 0.050 |
Why?
|
Research Design | 5 | 2016 | 6157 | 0.050 |
Why?
|
Phonocardiography | 3 | 1987 | 30 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5629 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2011 | 2144 | 0.050 |
Why?
|
Feasibility Studies | 5 | 2012 | 5199 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10748 | 0.050 |
Why?
|
History, 19th Century | 2 | 2017 | 720 | 0.050 |
Why?
|
Enzyme Replacement Therapy | 1 | 2021 | 79 | 0.050 |
Why?
|
Kidney Function Tests | 2 | 2015 | 677 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 1335 | 0.050 |
Why?
|
Kyphosis | 1 | 2003 | 237 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2008 | 2850 | 0.050 |
Why?
|
Sudden Infant Death | 1 | 1984 | 291 | 0.050 |
Why?
|
Williams Syndrome | 1 | 2003 | 193 | 0.050 |
Why?
|
Safety | 1 | 2005 | 1147 | 0.050 |
Why?
|
Tachycardia, Paroxysmal | 2 | 1996 | 30 | 0.050 |
Why?
|
Quality of Health Care | 2 | 2020 | 4317 | 0.050 |
Why?
|
Protein Precursors | 2 | 2018 | 1133 | 0.050 |
Why?
|
Proline | 1 | 1982 | 456 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10718 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1097 | 0.040 |
Why?
|
Pedigree | 3 | 2003 | 4578 | 0.040 |
Why?
|
Program Development | 3 | 2011 | 1298 | 0.040 |
Why?
|
Aspirin | 2 | 2007 | 3131 | 0.040 |
Why?
|
Pregnancy Outcome | 3 | 2007 | 2907 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2005 | 859 | 0.040 |
Why?
|
New England | 1 | 2003 | 1053 | 0.040 |
Why?
|
Myofibrils | 1 | 2020 | 141 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 2020 | 138 | 0.040 |
Why?
|
Electrodes | 3 | 1997 | 613 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 1983 | 634 | 0.040 |
Why?
|
Wisconsin | 1 | 2019 | 122 | 0.040 |
Why?
|
Edema | 1 | 2023 | 768 | 0.040 |
Why?
|
Rheumatic Heart Disease | 1 | 2001 | 165 | 0.040 |
Why?
|
Clinical Coding | 2 | 2011 | 180 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2012 | 2569 | 0.040 |
Why?
|
Child Welfare | 1 | 2003 | 516 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2000 | 229 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2003 | 944 | 0.040 |
Why?
|
Hypotension | 1 | 1985 | 879 | 0.040 |
Why?
|
Chelating Agents | 2 | 2014 | 383 | 0.040 |
Why?
|
Vascular Fistula | 1 | 1999 | 50 | 0.040 |
Why?
|
C-Reactive Protein | 3 | 2018 | 3812 | 0.040 |
Why?
|
Lung | 2 | 2015 | 9985 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2005 | 1190 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2002 | 540 | 0.040 |
Why?
|
Mothers | 2 | 2023 | 2189 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2012 | 4809 | 0.040 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2019 | 272 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2003 | 18119 | 0.040 |
Why?
|
Ventricular Septum | 1 | 2018 | 76 | 0.040 |
Why?
|
Aortic Arch Syndromes | 1 | 1998 | 19 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 959 | 0.040 |
Why?
|
Congresses as Topic | 2 | 2015 | 799 | 0.040 |
Why?
|
Acute Disease | 5 | 2011 | 7225 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1999 | 436 | 0.040 |
Why?
|
DiGeorge Syndrome | 1 | 1999 | 185 | 0.040 |
Why?
|
Virus Diseases | 2 | 1994 | 719 | 0.040 |
Why?
|
Health Personnel | 1 | 2011 | 3312 | 0.040 |
Why?
|
Anesthesia, General | 1 | 1985 | 1165 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3867 | 0.040 |
Why?
|
Kidney Transplantation | 2 | 2015 | 4217 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2005 | 1263 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12870 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 759 | 0.040 |
Why?
|
Physical Examination | 1 | 2003 | 1245 | 0.040 |
Why?
|
AIDS Dementia Complex | 1 | 1998 | 153 | 0.040 |
Why?
|
HIV-1 | 3 | 2002 | 6850 | 0.040 |
Why?
|
Insurance, Health | 1 | 2009 | 2495 | 0.040 |
Why?
|
Digoxin | 2 | 2012 | 246 | 0.040 |
Why?
|
Serum | 1 | 2018 | 210 | 0.040 |
Why?
|
Cost Savings | 2 | 2014 | 918 | 0.040 |
Why?
|
Artifacts | 1 | 2005 | 1897 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 432 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2023 | 1735 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2005 | 1115 | 0.030 |
Why?
|
Ethers | 1 | 1996 | 73 | 0.030 |
Why?
|
Missouri | 1 | 2016 | 114 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10146 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3992 | 0.030 |
Why?
|
Virulence | 1 | 2020 | 1298 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4429 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 1999 | 403 | 0.030 |
Why?
|
Halothane | 1 | 1996 | 200 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2004 | 1377 | 0.030 |
Why?
|
Risk | 3 | 2002 | 9599 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1632 | 0.030 |
Why?
|
Causality | 2 | 2016 | 1241 | 0.030 |
Why?
|
Medicaid | 1 | 2009 | 2807 | 0.030 |
Why?
|
Milrinone | 1 | 2016 | 86 | 0.030 |
Why?
|
Anesthesia, Inhalation | 1 | 1996 | 220 | 0.030 |
Why?
|
Growth Disorders | 2 | 2011 | 653 | 0.030 |
Why?
|
Neuroblastoma | 1 | 2004 | 1251 | 0.030 |
Why?
|
Patient Admission | 1 | 2003 | 1372 | 0.030 |
Why?
|
Nomograms | 1 | 2017 | 237 | 0.030 |
Why?
|
Brazil | 1 | 2019 | 1217 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 553 | 0.030 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 1996 | 65 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2020 | 832 | 0.030 |
Why?
|
Clinical Trials as Topic | 3 | 2006 | 7985 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2004 | 1160 | 0.030 |
Why?
|
Methyl Ethers | 1 | 1996 | 196 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3418 | 0.030 |
Why?
|
Running | 2 | 1992 | 483 | 0.030 |
Why?
|
Heart Conduction System | 2 | 2004 | 1011 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2014 | 51 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2014 | 69 | 0.030 |
Why?
|
Massachusetts | 3 | 2012 | 8823 | 0.030 |
Why?
|
Interprofessional Relations | 2 | 2011 | 989 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 2 | 1998 | 1088 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4106 | 0.030 |
Why?
|
Ohio | 1 | 2015 | 321 | 0.030 |
Why?
|
Sample Size | 1 | 2017 | 838 | 0.030 |
Why?
|
Recurrence | 4 | 2016 | 8426 | 0.030 |
Why?
|
Pulmonary Subvalvular Stenosis | 1 | 1993 | 7 | 0.030 |
Why?
|
Fetal Death | 2 | 2006 | 434 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 1996 | 582 | 0.030 |
Why?
|
Education, Medical | 1 | 2005 | 1725 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2014 | 213 | 0.030 |
Why?
|
Ligation | 1 | 1994 | 448 | 0.030 |
Why?
|
Elasticity | 1 | 2015 | 652 | 0.030 |
Why?
|
Decision Trees | 1 | 2015 | 504 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 2015 | 372 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 546 | 0.030 |
Why?
|
Heart Valve Prosthesis | 3 | 1997 | 1466 | 0.030 |
Why?
|
Coronary Angiography | 4 | 2012 | 4451 | 0.030 |
Why?
|
Cell Enlargement | 1 | 2013 | 60 | 0.030 |
Why?
|
Prenatal Diagnosis | 3 | 1996 | 1264 | 0.030 |
Why?
|
Prenatal Care | 1 | 2000 | 1129 | 0.030 |
Why?
|
Respiration, Artificial | 3 | 2012 | 2618 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9468 | 0.030 |
Why?
|
Dextrans | 2 | 1985 | 573 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 1995 | 463 | 0.030 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 1993 | 148 | 0.030 |
Why?
|
Ploidies | 1 | 2013 | 275 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 611 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2001 | 1313 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2016 | 5484 | 0.030 |
Why?
|
Tissue Donors | 1 | 2022 | 2311 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 4048 | 0.030 |
Why?
|
Status Asthmaticus | 1 | 1991 | 22 | 0.020 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 142 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 1996 | 908 | 0.020 |
Why?
|
Protein Conformation | 1 | 2020 | 3966 | 0.020 |
Why?
|
Cardiac Output, Low | 1 | 1992 | 191 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 1998 | 939 | 0.020 |
Why?
|
gamma-Globulins | 1 | 1991 | 123 | 0.020 |
Why?
|
Isoproterenol | 1 | 1991 | 394 | 0.020 |
Why?
|
Anesthetics, Inhalation | 1 | 1996 | 574 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 601 | 0.020 |
Why?
|
Atrophy | 1 | 1996 | 1627 | 0.020 |
Why?
|
Metabolism, Inborn Errors | 1 | 2013 | 285 | 0.020 |
Why?
|
Graft Survival | 1 | 2022 | 3794 | 0.020 |
Why?
|
Stroke | 3 | 2020 | 9694 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2608 | 0.020 |
Why?
|
Computer Simulation | 1 | 2004 | 6201 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8530 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2011 | 119 | 0.020 |
Why?
|
Protamines | 1 | 1991 | 112 | 0.020 |
Why?
|
Motion | 1 | 1994 | 779 | 0.020 |
Why?
|
Angiotensins | 1 | 2011 | 143 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1436 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3069 | 0.020 |
Why?
|
Texas | 1 | 2011 | 402 | 0.020 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 2001 | 139 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2014 | 1492 | 0.020 |
Why?
|
Adenoma | 1 | 2001 | 2148 | 0.020 |
Why?
|
DNA Primers | 1 | 2014 | 2816 | 0.020 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2004 | 504 | 0.020 |
Why?
|
Administration, Oral | 1 | 1998 | 3991 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2020 | 2621 | 0.020 |
Why?
|
Survival | 1 | 2010 | 160 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 1997 | 1489 | 0.020 |
Why?
|
Lactates | 1 | 1991 | 404 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1177 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 461 | 0.020 |
Why?
|
Myofibroblasts | 1 | 2011 | 207 | 0.020 |
Why?
|
Body Mass Index | 2 | 2020 | 12876 | 0.020 |
Why?
|
Tropomyosin | 1 | 2010 | 104 | 0.020 |
Why?
|
Random Allocation | 2 | 1996 | 2385 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2012 | 424 | 0.020 |
Why?
|
Health Services Accessibility | 2 | 2020 | 5404 | 0.020 |
Why?
|
Arterio-Arterial Fistula | 1 | 1989 | 20 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2013 | 624 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2011 | 361 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 414 | 0.020 |
Why?
|
Viral Load | 2 | 2013 | 3321 | 0.020 |
Why?
|
Portraits as Topic | 1 | 2008 | 32 | 0.020 |
Why?
|
Renin | 1 | 2011 | 635 | 0.020 |
Why?
|
Nutritional Status | 1 | 1997 | 1607 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18940 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 632 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2011 | 3671 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2020 | 2868 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2010 | 437 | 0.020 |
Why?
|
Chronic Disease | 3 | 2012 | 9267 | 0.020 |
Why?
|
Angiocardiography | 1 | 1988 | 153 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2010 | 427 | 0.020 |
Why?
|
Prolactin | 2 | 2001 | 621 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1842 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2513 | 0.020 |
Why?
|
Methods | 1 | 1988 | 1074 | 0.020 |
Why?
|
International Cooperation | 2 | 2005 | 1430 | 0.020 |
Why?
|
Pressure | 3 | 1988 | 1155 | 0.020 |
Why?
|
Hyperemia | 1 | 2009 | 221 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3612 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 1992 | 953 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2007 | 36 | 0.020 |
Why?
|
England | 1 | 2008 | 524 | 0.020 |
Why?
|
Infant Mortality | 1 | 2012 | 757 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2015 | 985 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2013 | 960 | 0.020 |
Why?
|
Brachial Artery | 1 | 2009 | 365 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2011 | 1593 | 0.020 |
Why?
|
Income | 1 | 2015 | 1872 | 0.020 |
Why?
|
Collagen Type I | 1 | 2010 | 616 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2010 | 434 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 1991 | 704 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 728 | 0.020 |
Why?
|
Thyrotropin | 2 | 2001 | 832 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2013 | 10416 | 0.020 |
Why?
|
Abortion, Therapeutic | 1 | 2006 | 35 | 0.020 |
Why?
|
Myocardial Ischemia | 2 | 1994 | 2108 | 0.020 |
Why?
|
Adaptation, Biological | 1 | 1987 | 147 | 0.020 |
Why?
|
Aldosterone | 1 | 2011 | 866 | 0.020 |
Why?
|
Comprehension | 1 | 2011 | 619 | 0.020 |
Why?
|
Atrial Appendage | 1 | 2010 | 282 | 0.020 |
Why?
|
Liver | 2 | 2018 | 7502 | 0.020 |
Why?
|
Office Visits | 1 | 2010 | 596 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1878 | 0.020 |
Why?
|
Fingers | 1 | 2009 | 506 | 0.020 |
Why?
|
Leukopenia | 1 | 2006 | 211 | 0.020 |
Why?
|
Medical Records | 2 | 2002 | 1406 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9404 | 0.020 |
Why?
|
Lactic Acid | 1 | 1991 | 1133 | 0.020 |
Why?
|
Twins, Conjoined | 1 | 1985 | 41 | 0.020 |
Why?
|
Dwarfism | 1 | 2006 | 137 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1993 | 1628 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8143 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3801 | 0.020 |
Why?
|
Deferoxamine | 1 | 1985 | 153 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1835 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2010 | 570 | 0.020 |
Why?
|
Body Weight | 2 | 2010 | 4603 | 0.020 |
Why?
|
Prealbumin | 1 | 2006 | 222 | 0.010 |
Why?
|
Acyltransferases | 1 | 2006 | 305 | 0.010 |
Why?
|
Cell Cycle | 1 | 2013 | 2930 | 0.010 |
Why?
|
Aged, 80 and over | 4 | 2012 | 58683 | 0.010 |
Why?
|
Monitoring, Physiologic | 3 | 1989 | 1780 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2008 | 759 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1984 | 63 | 0.010 |
Why?
|
Radiotherapy | 1 | 2011 | 1504 | 0.010 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2015 | 1452 | 0.010 |
Why?
|
Weight Gain | 1 | 2014 | 2346 | 0.010 |
Why?
|
Regeneration | 1 | 2013 | 1505 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2010 | 1296 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4711 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2006 | 629 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12436 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2925 | 0.010 |
Why?
|
Hand Strength | 1 | 2006 | 452 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 2003 | 186 | 0.010 |
Why?
|
Muscle Weakness | 1 | 2006 | 413 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7338 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1725 | 0.010 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2006 | 292 | 0.010 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1984 | 116 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2467 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2004 | 211 | 0.010 |
Why?
|
Syndrome | 2 | 2006 | 3262 | 0.010 |
Why?
|
Creatine Kinase, MB Form | 1 | 2003 | 202 | 0.010 |
Why?
|
Medical History Taking | 1 | 2006 | 772 | 0.010 |
Why?
|
Health Services Research | 1 | 2010 | 1812 | 0.010 |
Why?
|
Growth | 1 | 2004 | 365 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2071 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 415 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2008 | 827 | 0.010 |
Why?
|
Spinal Fusion | 1 | 1992 | 1280 | 0.010 |
Why?
|
Digitoxin | 1 | 1982 | 19 | 0.010 |
Why?
|
Peritoneal Dialysis | 1 | 2003 | 157 | 0.010 |
Why?
|
Bradycardia | 1 | 1984 | 299 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4113 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2635 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9160 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17617 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2492 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2717 | 0.010 |
Why?
|
Manometry | 1 | 1984 | 453 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1705 | 0.010 |
Why?
|
Thorax | 1 | 2004 | 553 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7021 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2011 | 2215 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 1991 | 2638 | 0.010 |
Why?
|
Baltimore | 1 | 2001 | 230 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7818 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4018 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23679 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 2 | 1997 | 864 | 0.010 |
Why?
|
Cadaver | 1 | 2004 | 1345 | 0.010 |
Why?
|
Pituitary Gland, Anterior | 1 | 1999 | 142 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2690 | 0.010 |
Why?
|
Movement | 1 | 2005 | 1474 | 0.010 |
Why?
|
Pain Measurement | 1 | 2009 | 3527 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2048 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2003 | 1694 | 0.010 |
Why?
|
Diuretics | 1 | 2001 | 610 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4341 | 0.010 |
Why?
|
RNA, Viral | 2 | 2001 | 2836 | 0.010 |
Why?
|
Mental Processes | 1 | 1999 | 245 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 1985 | 1184 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2692 | 0.010 |
Why?
|
Infant, Premature, Diseases | 1 | 1984 | 708 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2004 | 2896 | 0.010 |
Why?
|
Dogs | 1 | 1982 | 3840 | 0.010 |
Why?
|
Atrial Function, Right | 1 | 1997 | 32 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 1999 | 247 | 0.010 |
Why?
|
Equipment Design | 2 | 1997 | 3507 | 0.010 |
Why?
|
Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2269 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 2374 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2004 | 1927 | 0.010 |
Why?
|
Calcium | 1 | 2010 | 5721 | 0.010 |
Why?
|
Embolism, Air | 1 | 1997 | 110 | 0.010 |
Why?
|
Ethics, Medical | 1 | 2001 | 783 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 9051 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 1593 | 0.010 |
Why?
|
Infant, Premature | 1 | 2005 | 2092 | 0.010 |
Why?
|
Atrial Flutter | 1 | 1997 | 252 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6520 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2004 | 2297 | 0.010 |
Why?
|
Hypothalamus | 1 | 1999 | 998 | 0.010 |
Why?
|
Cineangiography | 1 | 1993 | 112 | 0.010 |
Why?
|
Electrophysiology | 1 | 1997 | 1263 | 0.010 |
Why?
|
Equipment Safety | 1 | 1995 | 250 | 0.010 |
Why?
|
HIV Antibodies | 1 | 2000 | 1300 | 0.010 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1994 | 173 | 0.010 |
Why?
|
Calcium-Transporting ATPases | 1 | 1993 | 122 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15773 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2009 | 3401 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81101 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2010 | 5331 | 0.010 |
Why?
|
Wheelchairs | 1 | 1992 | 78 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3915 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 4902 | 0.010 |
Why?
|
Proteins | 1 | 2006 | 6026 | 0.010 |
Why?
|
Cicatrix | 1 | 1997 | 781 | 0.010 |
Why?
|
Microcirculation | 1 | 1994 | 1273 | 0.010 |
Why?
|
Vasoconstriction | 1 | 1992 | 592 | 0.010 |
Why?
|
Autoradiography | 1 | 1990 | 730 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1994 | 1066 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1990 | 1304 | 0.000 |
Why?
|
Intraoperative Care | 1 | 1992 | 766 | 0.000 |
Why?
|
Angiography | 1 | 1993 | 1599 | 0.000 |
Why?
|
Capillaries | 1 | 1991 | 744 | 0.000 |
Why?
|
False Negative Reactions | 1 | 1988 | 573 | 0.000 |
Why?
|
Transcription Factors | 1 | 2006 | 12094 | 0.000 |
Why?
|
Thermodilution | 1 | 1986 | 51 | 0.000 |
Why?
|
Wound Healing | 1 | 1997 | 2783 | 0.000 |
Why?
|
Vena Cava, Inferior | 1 | 1988 | 458 | 0.000 |
Why?
|
Calcinosis | 1 | 1994 | 1467 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1988 | 956 | 0.000 |
Why?
|
Pediatric Nursing | 1 | 1986 | 104 | 0.000 |
Why?
|
Fibroblast Growth Factors | 1 | 1991 | 867 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1985 | 415 | 0.000 |
Why?
|
Injections, Subcutaneous | 1 | 1985 | 677 | 0.000 |
Why?
|
Computers | 1 | 1986 | 596 | 0.000 |
Why?
|
Swine | 1 | 1993 | 5892 | 0.000 |
Why?
|
DNA, Viral | 1 | 1990 | 2194 | 0.000 |
Why?
|
Anesthesia | 1 | 1992 | 1582 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1991 | 4540 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1993 | 12759 | 0.000 |
Why?
|
Patient Compliance | 1 | 1985 | 2685 | 0.000 |
Why?
|